Nephros Inc (NEPH) stock
NEPHNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 13/3023% below fair value
$2.90−0.10 (-3.33%)
Close on Nov 17, 2026Market cap $31.49MP/E 18.1Yield –
Nephros operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Nephros's operating income for the twelve months ending Jun 30, 2026 was $1.64M, up 22.8% year over year. For fiscal 2025 it was $1.15M, up 19000.0% from the year before. The highest annual figure on record is $1.15M in fiscal 2025.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.15M | +19000.0% |
| FY2024 | Dec 31, 2024 | $6.00K | – |
| FY2023 | Dec 31, 2023 | -$1.59M | – |
| FY2022 | Dec 31, 2022 | -$4.34M | – |
| FY2021 | Dec 31, 2021 | -$3.25M | – |
| FY2020 | Dec 31, 2020 | -$4.28M | – |
| FY2019 | Dec 31, 2019 | -$3.16M | – |
| FY2018 | Dec 31, 2018 | -$3.02M | – |
| FY2017 | Dec 31, 2017 | -$2.23M | – |
| FY2016 | Dec 31, 2016 | -$2.87M | – |
| FY2015 | Dec 31, 2015 | -$3.42M | – |
| FY2014 | Dec 31, 2014 | -$2.67M | – |
| FY2013 | Dec 31, 2013 | -$3.32M | – |
| FY2012 | Dec 31, 2012 | -$3.33M | – |
| FY2011 | Dec 31, 2011 | -$2.31M | – |
| FY2010 | Dec 31, 2010 | -$1.89M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $1.21M | +389.1% |
| Q1 FY2026 | Mar 31, 2026 | $97.00K | -82.9% |
| Q4 FY2025 | Dec 31, 2025 | $18.00K | -94.3% |
| Q3 FY2025 | Sep 30, 2025 | $314.00K | +52.4% |
| Q2 FY2025 | Jun 30, 2025 | $248.00K | – |
| Q1 FY2025 | Mar 31, 2025 | $566.00K | – |
| Q4 FY2024 | Dec 31, 2024 | $317.00K | – |
| Q3 FY2024 | Sep 30, 2024 | $206.00K | – |
| Q2 FY2024 | Jun 30, 2024 | -$317.00K | – |
| Q1 FY2024 | Mar 31, 2024 | -$200.00K | – |
| Q4 FY2023 | Dec 31, 2023 | -$649.00K | – |
| Q3 FY2023 | Sep 30, 2023 | -$203.00K | – |
| Q2 FY2023 | Jun 30, 2023 | -$435.00K | – |
| Q1 FY2023 | Mar 31, 2023 | -$306.00K | – |
| Q4 FY2022 | Dec 31, 2022 | -$693.00K | – |
| Q3 FY2022 | Sep 30, 2022 | -$1.28M | – |
| Q2 FY2022 | Jun 30, 2022 | -$814.00K | – |
| Q1 FY2022 | Mar 31, 2022 | -$1.55M | – |
| Q4 FY2021 | Dec 31, 2021 | -$721.00K | – |
| Q3 FY2021 | Sep 30, 2021 | -$802.00K | – |
| Q2 FY2021 | Jun 30, 2021 | -$1.12M | – |
| Q1 FY2021 | Mar 31, 2021 | -$1.02M | – |
| Q4 FY2020 | Dec 31, 2020 | -$719.00K | – |
| Q3 FY2020 | Sep 30, 2020 | -$932.00K | – |
| Q2 FY2020 | Jun 30, 2020 | -$1.60M | – |
| Q1 FY2020 | Mar 31, 2020 | -$1.03M | – |
| Q4 FY2019 | Dec 31, 2019 | -$291.00K | – |
| Q3 FY2019 | Sep 30, 2019 | -$695.00K | – |
| Q2 FY2019 | Jun 30, 2019 | -$868.00K | – |
| Q1 FY2019 | Mar 31, 2019 | -$1.30M | – |
| Q4 FY2018 | Dec 31, 2018 | -$729.00K | – |
| Q3 FY2018 | Sep 30, 2018 | -$511.00K | – |
| Q2 FY2018 | Jun 30, 2018 | -$653.00K | – |
| Q1 FY2018 | Mar 31, 2018 | -$1.12M | – |
| Q4 FY2017 | Dec 31, 2017 | -$403.00K | – |
| Q3 FY2017 | Sep 30, 2017 | -$518.00K | – |
| Q2 FY2017 | Jun 30, 2017 | -$700.00K | – |
| Q1 FY2017 | Mar 31, 2017 | -$605.00K | – |
| Q4 FY2016 | Dec 31, 2016 | -$609.00K | – |
| Q3 FY2016 | Sep 30, 2016 | -$637.00K | – |
See a number that looks wrong?